Rochester,NY 9/2/2009 1:10:21 AM
ACHN, Achillion Pharmaceuticals, Inc. Trade Drops 6.40% At The Last Hours Of The Day.
Achillion Pharmaceuticals, Inc.
ACHN, Achillion Pharmaceuticals, Inc. Trade Drops 6.40% At The Last Hours Of The Day.
Achillion Pharmaceuticals, Inc.ACHN, a biopharmaceutical company began the day at 1.83, Which stayed the maximum range not more than 1.83 on volume of 13,060. At the end session of day the stock ranged from 1.70 - 1.83 with an average volume of 22,933.8 shares.
http://StockEinstein.com offers free daily stock alerts on companies ready to run. Scroll to BOTTOM of this page for free stock alerts, or visit our site.
Last Trade: 1.75
Day's Range: 1.70 - 1.83
52wk Range: 0.65 - 2.60
Change: Down 0.06 (3.31%)
Volume: 13,060
Avg Vol (3m): 22,933.8
ABOUT Achillion Pharmaceuticals, Inc.
Achillion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for infectious diseases. The company focuses on the development of antiviral for the treatment of chronic hepatitis C and HIV infection; and the development of antibacterials for the treatment of resistant bacterial infections. Its products include ACH-1095, a NS4A antagonist that is in late-stage pre clinical studies for the treatment of chronic hepatitis C infections; ACH-1625, a protease inhibitor, which is in the preparation for phase I initiation for the treatment of chronic hepatitis C infections; ACH-702, a preclinical candidate that is in preclinical stage with potency against a spectrum of bacterial pathogens, including methicillin-resistant staphylococcus aureus for drug resistant bacterial infections; and Elvucitabine, which completed phase II studies for the treatment of HIV infection. The company has a collaboration arrangement with Gilead Sciences, Inc. to develop and commercialize compounds for use in treating hepatitis C infection, which inhibit viral replication through a mechanism of action. The company was founded in 1998 and is based in New Haven, Connecticut.
About Stock Einstein
StockEinstein uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance. We utilize not only software, but time tested criteria to uncover these potential winners. When these benchmarks are reached or exceeded, our subscribers are immediately notified.
This service is free and available only to subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
Disclaimer: Full disclaimer at http://StockEinsteain.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinsteain, nor any of its affiliates are registered investment advisors or broker dealers.
